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Abstract
Background: The Papua New Guinea Department of Health recently shifted from a presumptive to a ‘test and
treat’ malaria case management policy. This shift was supported by the widespread introduction of malaria rapid
diagnostic tests in health facilities across the country. Health workers received training and job-aids detailing how
to conduct and interpret a malaria rapid diagnostic test and how to treat test positive cases; however, little
instruction on treating non-malaria febrile cases was provided. Accordingly, this study examined health worker case
management of non-malarial febrile patients in the 12-month period immediately following the introduction of the
revised malaria case management policy.
Methods: Data were collected from a country-wide cross-sectional survey of febrile case management at randomly
selected health facilities and from longitudinal surveillance at sentinel health facilities. Analysis was restricted to
febrile patients who tested negative for malaria infection by rapid diagnostic test (N=303 and 5705 outpatients,
respectively).
Results and Discussion: 96.8% of non-malarial febrile patients received a diagnosis in the longitudinal sample,
compared to 52.4% of the cross-sectional sample. Respiratory tract infections were the most commonly reported
diagnoses. Over 90% of patients in both samples were prescribed one or more medications, most commonly an
analgesic (71.3 & 72.9% of the longitudinal and cross-sectional samples, respectively), some form of antibiotic (72.7
& 73.4%, respectively) and/or an anthelminthic (17.9 & 16.5%, respectively). Prescribing behaviour was adherent with
the recommendations in the standard treatment guidelines in fewer than 20% of cases (longitudinal sample only).
Conclusion: Many non-malarial febrile patients are not provided with a diagnosis. When diagnoses are provided
they are typically some form of respiratory tract infection. Antibiotics and analgesics are widely prescribed, although
medications prescribed rarely adhere to the Papua New Guinea standard treatment guidelines. These findings
indicate that Papua New Guinea health workers require support for non-malarial febrile illness case management.
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Background
The last 5 to 10 years has seen a substantial increase in
the availability and use of malaria Rapid Diagnostic Tests
(mRDTs) in many parts of the world [1]. Consistent with
these global trends, Papua New Guinea (PNG) with sup-
port from a Round 8 Global Fund grant has procured
over three million mRDTs since 2010 [2]. This supports
a revised national malaria treatment policy (NMTP)
stipulating that all fever or suspected malaria cases be
tested for malaria infection by microscopy or mRDT [3].
Internationally, the scale-up of mRDT availability has
often led to substantial reductions in antimalarial
prescription as health workers shift from a presumptive
to a ‘test and treat’ malaria case management approach
[4–6]. There is some evidence to suggest a similar
change in health worker practice is occurring in PNG. A
recent study found that antimalarial prescriptions to fe-
brile patients declined from 96.4% of cases before the
introduction of the test and treat policy to 39.0% in the
12-month period immediately post-implementation [7].
The availability of mRDTs increased from 8.9% of sur-
veyed facilities to 53.4% across the same time period.
Whilst mRDTs can confirm or rule out malaria infec-
tion, they provide no support to health workers for diag-
nosing and treating non-malarial fevers. Fever is an
unspecific syndrome and diagnostic tools to assist in the
accurate identification of its aetiology in mRDT negative
patients are scarce in resource-poor settings [8]. The his-
toric practice of presumptive malaria diagnosis may fur-
ther undermine the quality of non-malarial febrile case
management as the health workforce has little acquired
experience in the clinical diagnosis and treatment of
non-malarial febrile patients [9]. Many febrile patients
attending PNG health facilities test negative for malaria
infection and the malaria burden is declining in the gen-
eral population [10, 11]. Thus, the health workforce is
increasingly, and quite suddenly, required to respond to
febrile illnesses shown to be non-malarial in origin via
mRDT.
A health worker training program was carried out in
PNG pre-implementation of the new NMTP. This pro-
gram provided detailed instruction on mRDT use and
strongly emphasised the importance of restricting anti-
malarial prescription to test-confirmed cases [12].
Nevertheless, the training program provided relatively
little detail on non-malarial febrile case management be-
yond reference to an Integrated Management of Child-
hood Illness (IMCI) flowchart. No instruction on the
management of non-malarial febrile illness in adolescent
or adult patients was provided. The PNG National De-
partment of Health and the Paediatric Society of PNG
issues standard treatment guidelines which outline rec-
ommended management of a range of common illnesses,
including non-malarial febrile illness [13, 14]. Apart
from these reference manuals, no other training, re-
sources or support have been specifically provided to as-
sist the PNG healthcare workforce manage the
increasing number of non-malarial febrile illness cases
identified in the context of the new NMTP. Accurate
diagnosis of non-malarial febrile illness is further com-
prised by the absence of on-site laboratory support at
most primary health care facilities in PNG [15]. The
general lack of curative treatments for most viral febrile
illnesses may be an additional obstacle to implementing
accurate evidence-based treatment.
This paper examines how the PNG primary healthcare
workforce diagnosed and treated non-malarial febrile pa-
tients in the period immediately following the wide-
spread introduction of mRDTs. The primary research
questions included: what percentage of non-malarial fe-
brile patients are provided a recorded diagnosis? What
diagnoses are being recorded? What medications are be-
ing prescribed? And to what extent do the medications
prescribed adhere with national standard treatment
guidelines?
Methods
This paper presents selected data from a multifacted
evaluation of the PNG National Malaria Control Pro-
gram (NMCP), 2009–2014. A full description of the
NMCP evaluation is available elsewhere [16]. Reported
data were obtained from longitudinal, outpatient surveil-
lance in seven sentinel health facilities and a cross sec-
tional survey completed in 36 randomly selected health
facilities across the country. The longitudinal dataset
provided a large number of febrile cases, although the
respective case management of these patients was pro-
vided by a relatively small number of health workers
working within a quasi-research environment. The cross
sectional dataset provided fewer clinical cases, but these
cases were clinically managed by a greater number of
health workers from across a greater number of health
facilities in a routine clinical environment. The datasets
are considered complementary as, together, they provide
clinical case management records pertaining to non-




Outpatient surveillance was variously initiated in seven
sentinel primary health care facilities across PNG between
January 2010 and July 2011. The primary aim of the sur-
veillance was to assess trends in malaria morbidity. The
seven facilities were purposively selected from a sampling
frame of operational public-sector health centres provided
by the PNG Department of Health according to their ac-
cessibility, their functionality, their geographical spread
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and the local malaria epidemiology and were located in
Balimo (Western province), East Cape (Milne Bay prov-
ince), Karimui (Chimbu province), Sausi (Madang prov-
ince), Dreikikir (East Sepik province), Lemakot (New
Ireland province) and Arawa (Autonomous Region of
Bougainville). For the purpose of this paper, focus is
placed on data collected in the calendar year 2012 as the
revised NMTP was implemented in November, 2011.
Procedure
Daily surveillance was carried out at each health facility
during regular opening hours (Monday to Friday,
7.45 am-4.06 pm). Outpatients presenting with fever or
a history of fever, in the past 3 days, were referred to a
study nurse who then completed an mRDT, prepared a
thick and thin blood smear on a microscopy slide and
measured haemoglobin (Hb) level using a Hemocue Hb
201+ analyser (HemoCue AB, Ängelholm, Sweden).
Demographic details of the patient were recorded in a
one-page case report form alongside clinical signs and
symptoms, previous health facility attendance and drug
intake, axillary temperature, weight and results of the
mRDT and Hb measurement. The patient was then
transferred to a member of the respective facility’s health
work force for further examination, diagnosis and treat-
ment following routine procedures. The resulting diag-
nosis and any prescription by the health worker were
recorded on the case report form. Oral informed con-




The sample consisted of primary health care facilities
randomly selected as part of a countrywide cross sec-
tional health facility survey in which at least one in-
stance of febrile case management has been observed by
a member of the research team. The sampling frame
consisted of all primary health care facilities operational
at the time of the survey. Health facilities were stratified
by province and selected using a simple random sam-
pling procedure. Sample size was determined by logis-
tical considerations.
Procedure
The survey was carried out between June and November
2012. Research officers spent between 1 to 5 days at
each participating health facility (depending on size). Up
to four different survey instruments were completed at
each health facility, although this paper only reports data
obtained from the non-participant observation of febrile
case management (described below). Oral informed con-
sent was sought from the officer in charge at all partici-
pating health facilities and from all participating
clinicians and patients prior to clinical observation.
More details of the general survey methodology have
been published elsewhere [7].
Survey instrument
A structured checklist was designed to record observed
features of the clinical case management of patients pre-
senting with fever or a recent history of fever. The in-
strument was divided into discrete sections including
consultation and diagnosis, prescription and treatment
counseling. The content of each section was informed
with input from experienced medical- and medical re-
search- professionals. The instrument was completed by
a trained research officer who would passively observe
the management of fever patients from the point of ini-
tial contact with a health professional until service exit
or admission onto a treatment ward. During the course
of this observation, the research officer recorded on the
structured clinical observation instrument whether spe-
cified actions did or did not occur and recorded the con-
tent of specific actions (e.g., whether an mRDT was
conducted and, if yes, the outcome). Eligible patients
were identified upon first contact with a health worker
or, if circumstances allowed, by screening in the waiting
area prior to first contact with a health worker.
Data analysis
All data were double entered into DMSys version 5.1
(Sigma Soft International). Stata versions 11/IC and 12/
SE were used for descriptive data analysis and to assess
health worker adherence to prescription guidelines. The
analysis of health worker adherence to prescription
guidelines was limited to the ten most frequently re-
corded diagnoses and to patients with a single recorded
diagnosis. Patients with multiple diagnoses were not in-
cluded as it was not possible to determine which medi-
cations were prescribed for which diagnosis. To be rated
‘adherent’ the medications prescribed were required to
be consistent with those listed against the specified diag-
nosis in either the Papua New Guinea Standard Treat-
ment Guidelines for Adults [14] or Children [13], as
listed in Table 1. A rating of ‘partially adherent’ was
given when at least one (but not all) of the listed medi-
cations for the specified diagnosis were prescribed or the
same class of medication was prescribed, but not the
recommended drug. A rating of ‘non-adherent’ was
given when the medication/s prescribed was/were nei-
ther the recommended drug nor the same class of medi-
cation as stated in the aforementioned manuals. The
analysis of health worker adherence to prescription
guidelines did not account for drug dosages and was not
applied to the CS sample due to the large number of
cases without a recorded diagnosis. Between-group dif-
ferences in the mean number of medications prescribed
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and type of prescription were examined by two-tailed t-




A total of 5705 patients with fever or recent experience
of fever tested negative for malaria by mRDT across the
seven sentinel sites in 2012. Of these patients, 50.9%
were female, 42.3% were <5 years of age, 18.7% were be-
tween 5 and 15 years of age and 39.0% were 16 years of
age or older.
Diagnosis
A diagnosis was recorded for 96.8% (5521/5705) of
the outpatient surveillance (OS) sample. Of outpa-
tients with a recorded diagnosis, 88.9% (4906/5521)
had one recorded diagnosis and 11.1% (615/5521) had
two or more. Overall, a total of 6152 diagnoses were
recorded of which 87.6% (5391/6152) appear in the
Papua New Guinea Standard Treatment Guidelines
for Adults [14] or Children [13]. A full list of the re-
corded diagnoses is available in Additional file 1. The
ten most frequently recorded diagnoses, accounting
for 72.6% (4469/6152) of all diagnoses, included:
Pneumonia (n = 824), Cough (n = 790), Respiratory
Tract Infection (n = 613), Malaria (n = 510), Anaemia
(n = 452), Fever of Unknown Origin (n = 399), Otitis
Media (n = 286), Diarrhoea (n = 274), Flu (n = 233)
and Worms (n = 88).
All participants included in the OS sample were tested
for malaria and anaemia using diagnostic tests. These
were the only two diagnostic test results routinely re-
corded that allow the accuracy of the respective diagno-
sis to be assessed. By definition, all participants included
in the OS sample tested negative for malaria infection by
mRDT; however, 8.9% (510/5705) were given a recorded
diagnosis of malaria all of which would be considered in-
correct according to mRDT result assuming absence of
signs of severe malarial disease (7/510 malaria diagnose
were recorded as ‘severe malaria’). Anaemia was defined,
by the Papua New Guinea Standard Treatment Guide-
lines, as any patient presenting with Hb less than 10 g/
dL. A Hb level lower than 5 g/dL indicates severe an-
aemia. Overall, 27.4% (1561/5705) of the OS sample
tested positive for either moderate (n = 1481) or severe




Anaemiaa Fefol; Albendazole; if spleen is very large, Chloroquine Antimalarial + Albendazole + Folic Acid + Iron
(for severe cases a blood transfusion)
Coughb Amoxicillin + Paracetamol (if simple cough) Amoxicillin
Diarrhoeac Treat dehydration with Oral Rehydration Salts (ORS);
in severe cases treat intravenously with ORS
Treat dehydration with Oral Rehydration Salts (ORS);
in severe cases treat intravenously with ORS
Gastroenteritisc Treat dehydration with Oral Rehydration Salts (ORS);
in severe cases treat intravenously with ORS
Treat dehydration with Oral Rehydration Salts (ORS);
in severe cases treat intravenously with ORS
Influenza-like-
illness
Amoxicillin (bacterial infection) + Paracetamol (fever) Amoxicillin (bacterial infection) + Paracetamol (fever)
Malariad P.falciparum: Artemether Lumefantrine (AL); P.vivax:
AL + Primaquine
P.falciparum: Artemether Lumefantrine (AL); P.vivax:
AL + Primaquine
Otitis Mediae Amoxicillin + Paracetamol (acute otitis media);
Co-trimoxazole (for pus in chronic Otitis media)
Amoxicillin + Paracetamol (acute otitis media); Co-trimoxizole
(if pus/discharge after 1 week of treatment); Boric Acid ear drops
(Chronic Otitis Media)
Pneumoniaf Paracetamol (chest pains) + Amoxicillin (mild, moderate);
Benzyl-penicillin (severe); Chloramphenicol (severe);
gentamicin (severe); ceftriaxone (severe) + Oxygen (severe)
+ nebulised salbutamol (for wheezing); salbutamol inhaler
(for wheezing)
Chloramphenicol (severe pneumonia) + Oxygen (if child is cyanosed/
grunting/in heart failure/restless/drowsy/stopping breathing); Benzyl
Penicillin (moderate pneumonia); Amoxicillin (mild pneumonia)
URTIg Amoxicillin (bacterial infection) + Paracetamol (fever) Amoxicillin (bacterial infection) + Paracetamol (fever)
Worms Albendazole Albendazole
aIncludes severe anaemia, anaemia acquired in pregnancy, anaemia acquired after birth and non-specific anaemia
bIncludes general cough, simple cough and productive cough
cA rating could not be made in the majority of cases due to insufficient diagnostic information (e.g., diarrhoea would be treated in different ways depending on
the cause, but the cause was rarely stated)
dIncludes uncomplicated malaria, severe malaria and non-specific malaria
eIncludes both acute and chronic otitis media as well as non-specific otitis media
fIncludes moderate, mild and severe pneumonia
gUpper Respiratory Tract Infection
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anaemia (n = 80). Of these 1561 patients, 24.9% were for-
mally diagnosed with anaemia.
Medication
Ninety-six point five percent (5508/5705) of the OS
sample were prescribed one or more medications, the
number, percentage and type of which are depicted in
Table 2. The mean number of medications prescribed
(analysis restricted to patients prescribed at least one
medicine) was 1.8 (Median 1; IQR 1–2). Overall, antibi-
otics were the most commonly prescribed medication
(72.7%), followed by analgesics (71.3%) and anthel-
minthics (17.9%). One or more antimalarial medications
were prescribed to 13.2% (753/5705) of the OS sample,
the most common of which were sulphadoxine/pyri-
methamine (SP) (8.1%), chloroquine (4.2%) and amodia-
quine (3.6%). 58.6% (441/753) of these patients received
some form of antimalarial combination, the most com-
mon of which were SP plus chloroquine (21.1%), and SP
plus amodiaquine (19.1%). Artemether monotherapies
were prescribed in 2.9% (22/753) of cases.
Health worker adherence to prescription guidelines
As shown in Table 3, a total of 3249 patients met the in-
clusion criteria for this analysis of whom 16.6% received
a prescription in adherence with the standard treatment
guidelines for their respective diagnosis. The majority of
prescriptions (56.3%) were rated ‘partially adherent’,
21.8% ‘non-adherent’ and a rating was unable to be
made in 5.4% of cases.
Table 4, drawing on the same sample as presented in
Table 3 and further limited to those patients for whom it
was possible to provide an ‘adherence’ rating (n = 3075),
presents the percentage of participants for whom: ac-
cording to the respective prescription protocols in the
PNG standard treatment guidelines, (1) should have
been prescribed an antibiotic and were not (under pre-
scription); and (2) should not have been provided an
antibiotic and were (over prescription). As shown, 18.7%
of patients in the five diagnostic categories in which an
antibiotic should have been prescribed did not receive
an antibiotic. Conversely, 41.0% of patients in the five
diagnostic categories in which an antibiotic should not
have been prescribed did receive an antibiotic.
Cross sectional survey
Sample
A total of 303 febrile patients tested negative for malaria
by mRDT or microscopy. Of these patients, 50.8% were
female, 47.9% were <5 years of age, 19.5% were between
5 and 15 years of age and 32.7% were 16 years of age or
older. These patients were collectively observed across
36 health facilities in 17 provinces.
Diagnosis
A diagnosis was only sought for mRDT negative patients
not prescribed an antimalarial (n = 246) as those pre-
scribed antimalarials (n = 57) were assumed to have been
diagnosed with malaria despite the mRDT result. Of
these 246 patients, a diagnosis was recorded in 52.4% of
cases. The specified diagnoses indicated some form of
respiratory tract infection (n = 80), general body aches or
headache (n = 28), fever (n = 11), diarrhoea (n = 9), ear
infection (n = 7), shortness of breath (n = 7), sore mouth/
throat (n = 5), influenza (n = 4), viral infection (n = 3),
malaise (n = 3), vomiting (n = 2), food poisoning (n = 2)
and one each of measles, tuberculosis, anaemia, gastro-
enteritis, swelling, bleeding eye, pregnancy and
hypertension.
Of the 117 mRDT negative patients without a re-
corded diagnosis (or prescribed antimalarials), 94.0%
(110/117) were prescribed some form of medication sug-
gesting the health worker formed a clinical opinion as to
the cause of the febrile illness even if this opinion was
not formally recorded or reported to the patient.
Medication
97.0% (294/303) of the CS sample were prescribed one
or more medications, the number, percentage and type
of which are listed in Table 2. The mean number of
medications prescribed (analysis restricted to patients
prescribed at least one medicine) was 2.1 (Median 2;
IQR 2–3). Overall, antibiotics were the most commonly
prescribed medication (73.4%) followed by analgesics
(72.9%). One or more antimalarial medications were
prescribed to 18.8% (57/303) of the CS sample despite
the negative mRDT result. The most commonly pre-
scribed antimalarials were SP (13.9%), amodiaquine
(6.9%) and chloroquine (6.6%). The recommended first
line medication for uncomplicated malaria, artemether-
lumefantrine, was prescribed in 1.0% (3/303) of cases.
13.9% (42/303) of these patients received some form of
antimalarial combination, the most common of which
were chloroquine plus SP (6.6%), amodiaquine plus SP
(5.0%) and artemether/artesunate plus SP (1.7%). Arte-
mether monotherapies were prescribed in less than
1.0% (2/303) of cases.
Excluding patients prescribed an antimalarial (for
whom diagnostic information was not sought), there
was no statistically significant difference in the mean
number of medications prescribed to mRDT negative
patients with a recorded diagnosis as compared to
those without a recorded diagnosis (2.0 vs. 1.9; t = −0.3,
p = 0.76). Furthermore, mRDT negative patients not
provided a diagnosis were as likely to receive an anti-
biotic (75.9% vs. 73.1%; χ2 = 0.7, p = 0.42) or analgesic
(71.6% vs. 76.2%; χ2 = 0.7, p = 0.41) as those with a
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recorded diagnosis suggesting prescribing behaviour
was similar irrespective of whether a formal diagnosis
was recorded or not.
Discussion
This paper presents data pertaining to the clinical case
management of non-malarial febrile patients in the 12-
month period immediately following the discontinuation
of a treatment protocol in which most febrile patients
were presumptively treated with antimalarials. Data were
derived from longitudinal surveillance in seven out-
patient sentinel health facilities and from a cross sec-
tional survey in 36 health centres across 17 provinces in
PNG.
Findings from the OS sample indicate that the vast
majority of non-malarial febrile patients had a formal
diagnosis recorded, in the CS sample this was little more
than 50%. As the latter comprised a greater number of
health workers, and as these health workers were not
prompted to provide a diagnosis (as was the case in the
OS sample), then the CS percentage may be the more
accurate reflection of standard practice. Respiratory tract
infections, often pneumonia, were the most common
diagnosis provided across both datasets. Diagnoses of
diarrhoea and general body aches were also prominent
across samples, although at a substantially lower fre-
quency. Respiratory tract infections and diarrhoea have
historically been reported at a high frequency on the
PNG National Health Information System [17] and are
ranked highly in PNG burden of disease estimates [18].
Thus, the specified diagnoses of non-malarial febrile ill-
ness are largely consistent with existing data sources.
It was not possible to determine whether the recorded
diagnoses were accurate or not in the context of this
study, with the exception of malaria and anaemia. How-
ever, the small number of studies that have examined
the aetiology of non-malarial febrile illness in PNG have
identified dengue as a cause in approximately 10% of
cases [19, 20] and a chikungunya virus outbreak was de-
tected in PNG at the time the reported data were col-
lected [21, 22]. A recent review of non-malarial febrile
Table 2 Number, percent and type of prescribed medications
by survey type






n % n %
Antimalarial 753 13.2 57 18.8
Amodiaquine 203 3.6 21 6.9
Artemether 160 2.8 7 2.3
Artemether-Lumefantrine 52 0.9 3 1.0
Artesunate 12 0.2 1 0.3
Chloroquine 240 4.2 20 6.6
Dihydroartemisinin-Piperaquine 1 0.02 0 0
Doxycycline 91 1.6 2 0.6
Primaquine 13 0.2 1 0.3
Quinine 6 0.1 0 0
Sulfadoxine-Pyrimethamine 461 8.1 42 13.9
Antibiotic 4147 72.7 223 73.4
Amoxicillin 1429 25.0 124 40.9
Co-trimoxazole 1179 20.7 70 23.1
Benzylpenicillin 478 8.4 42 13.9
Chloramphenicol 129 2.3 12 4.0
Metronidazole 32 0.6 3 1.0
Erythromycin 49 0.9 1 0.3
Eye ointment 20 0.4 1 0.3
Analgesic/antipyretic 4068 71.3 221 72.9
Aspirin 261 4.6 28 9.2
Paracetamol 3765 66.0 190 62.7
Indomethacin 32 0.6 3 1.0
Haematinics 438 7.7 10 3.3
Ferrous salt + folic acid 419 7.3 9 2.9
Interferon 19 0.3 1 0.3
Gastro Intestinal 19 0.3 5 1.7
Cimetidine 4 0.1 1 0.3
Aluminium-Hydroxide 15 0.3 3 1.0
Anti-diabetic 3 0.1 0 0
Metaformin 3 0.1 0 0
Anticonvulsant 2 0.04 1 0.3
Phenobarbitone 0 0 1 0.3
Antiprotozoal 343 6.0 17 5.6
Tinidazole 343 6.0 16 5.3
Anthelminthic 1022 17.9 50 16.5
Albendazole 1022 17.9 42 13.9
Corticosteroid 0 0 1 0.3
Prednisolone 0 0 1 0.3
Bronchodilator 76 1.3 0 0
Salbutamol 74 1.3 0 0
Table 2 Number, percent and type of prescribed medications
by survey type (Continued)
Antifungal 12 0.2 1 0.3
Dermatological lotion 7 0.1 1 0.3
Dermatological oral drugs 5 0.1 0 0
Cardio-vascular 3 0.1 0 0
Methyldopa 3 0.1 0 0
Rehydration 82 1.4 0 0
Oral rehydration salts 73 1.3 1 0.3
Glucose 9 0.2 0 0
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illness in the neighbouring South East Asia region fur-
ther identified dengue, typhus and Leptospira spp. as the
most commonly reported pathogens across 146 studies
meeting the inclusion criteria [23]. As neither dengue,
chikungunya, typhus or leptospira spp. were diagnosed
in a single case in either sample, as malaria was diag-
nosed in between 8.9 to 18.8% of mRDT-negative cases
and as anaemia was substantially underdiagnosed despite
the availability of a Hb-measurement in the OS sample,
there is reason to question the accuracy of recorded
diagnoses. The limited diagnostic/laboratory support
available in primary health care facilities in PNG restricts
the degree to which health workers can investigate the
causes of febrile illnesses and may consequently influ-
ence the accuracy of diagnoses provided. The threat of
misdiagnosis may, therefore, be considered a result of
limitations in the broader healthcare system rather than
health worker ability per se.
Prescription patterns were consistent across datasets.
Over 90% of patients in both the OS and CS sample
were prescribed one or more medications, most com-
monly some form of antibiotic, analgesic and/or anthel-
minthic. Antimalarials were provided in 18.8 and 13.2%
of OS and CS cases, respectively, despite the negative
mRDT result. This rate of antimalarial prescription to
mRDT negative patients is lower than that reported in
other settings [24–26] and represents a substantial re-
duction in the rate of antimalarial prescription to febrile
patients compared to the practice observed prior to the
change in treatment protocol [27]. Thus, while not fully
compliant with the revised protocol, PNG health
workers have seemingly made radical and appropriate
adjustments to their antimalarial prescription practices
in a relatively brief time frame and perhaps at a faster
rate than their international peers in similar
circumstances.
The adherence analysis indicated that the prescription
provided was consistent with that recommended in the re-
spective PNG standard treatment manual for the specified
diagnosis in fewer than 20% of cases (OS sample only).
The majority of prescriptions (56.3%) were rated ‘partially
adherent’, indicating that at least one, but not all, of the
recommended medications was provided or the correct
class of medication was provided, but not the recom-
mended drug. It was not possible to determine what influ-
ence the availability of the respective medications played
in this outcome. This result, therefore, most likely reflects
limitations in both medication availability and health
worker practice, yet it remains the case that the medica-
tions provided were rarely in full accordance with those
recommended for the diagnoses given. A previous study,
not restricted to mRDT negative cases, reported ‘appropri-
ate’ prescription rates (based on diagnosis) of between
62.1–69.6% in two secondary care settings and an
Table 3 Health worker adherence to prescription guidelines
relative to recorded diagnosis







Anaemiaa 270 3.7 90.7 5.6 0
Coughb 639 8.5 37.4 54.1 0
Diarrhoeac 174 0 36.8 0 63.2
Gastroenteritisc 71 0 19.7 0 80.3
Influenza-like-
illness
207 2.9 36.7 57 3.4
Malariad 346 5.2 83.2 11.6 0
Otitis Mediae 238 30.3 68.9 0.8 0
Pneumoniaf 715 38.7 59.6 1.7 0
URTIg 526 15.8 52.1 32.1 0
Worms 63 31.7 60.3 7.9 0
Total 3249 16.6 56.3 21.8 5.4
aIncludes severe anaemia, anaemia acquired in pregnancy, anaemia acquired
after birth and non-specific anaemia
bIncludes general cough, simple cough and productive cough
cA rating could not be made in the majority of cases due to insufficient
diagnostic information (e.g., diarrhoea would be treated in different ways
depending on the cause, but the cause was rarely stated)
dIncludes uncomplicated malaria, severe malaria and non-specific malaria
eIncludes both acute and chronic otitis media as well as non-specific
otitis media
fIncludes moderate, mild and severe pneumonia
gUpper Respiratory Tract Infection
Table 4 Antibiotic prescription relative to diagnosis, according
to Papua New Guinea Standard Treatment Guidelines
Diagnosis Number Antibiotic Prescription (%)
Required Undera Overb
Anaemia 270 NO - 54.8
Cough 639 YES 37.4 -
DiarrhoeaC 64 NO - 92.2
GastroenteritisC 14 YES 0 -
Influenza-like-illnessC 200 NO - 37.0
Malaria 346 NO - 19.1
Otitis Media 238 YES 2.9 -
Pneumonia 715 YES 3.1 -
URTI 526 YES 24.9 -
Worms 63 NO - 63.5
Total 3075 - 18.7 41.0
aPercentages only calculated for patients in those diagnostic categories in
which the PNG standard treatment quidelines recommend an antibiotic
prescription (n = 2132)
bPercentages only calculated for patients in those diagnostic categories in
which the PNG standard treatment quidelines do not recommend an
antibiotic prescription (n = 943)
cAnalysis limited to those participants for whom an ‘adherence rating’
(Table 2) could be made
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outpatient facility in PNG [28]. Thus, the relatively poor
adherence to prescription guidelines reported in this study
suggests that PNG health workers may be less likely to
provide a recommended prescription when treating non-
malarial febrile illness patients. However, in the absence of
an expert reference diagnosis in the context of this study,
the extent and consequences of any potential misdiagnosis
and non-recommended prescription cannot be judged.
Previous studies have reported similar rates of anti-
biotic prescription to mRDT negative patients as re-
ported here, from 61.4% in Uganda [29] to 78% in
Tanzania [30]. Accordingly, the rates may be considered
somewhat normative in a low income country setting in
which a shift from presumptive to parasitological con-
firmed malaria diagnosis has recently taken place.
Nevertheless, the rate of antibiotic prescription is high
and raises the possibility that primary health care
workers in PNG may be substituting antimalarial medi-
cation with antibiotic medication in response to the re-
vised NMTP, as has been previously suggested [6, 9].
The potential over-prescription of antibiotics cannot be
reliably established in the absence of an expert reference
diagnosis including, in some instances, additional diag-
nostic testing; nevertheless, a recent study reported un-
necessary antibiotic prescription in 29% of 6969
observed illness episodes in outpatient health services in
PNG [31] which is somewhat consistent with the rate of
antibiotic over prescription (41%) reported herein. Fur-
thermore, an analysis of medication prescription to mal-
aria mRDT positive patients in the CS survey [7] found
that out of 54 mRDT positive patients, 98.2% were pre-
scribed an antimalarial, yet only 14.8% were prescribed
an antibiotic. This would indicate that health workers
are selectively (and often unnecessarily) prescribing anti-
biotics to mRDT negative cases as opposed to routinely
providing them to all febrile patients.
This study was not without limitation. Firstly, the fact
that (to a large extent) the accuracy of the reported diag-
noses was not able to be assessed in either the OS or CS
sample remains an important knowledge gap. Whilst
assessing the accuracy of non-malarial febrile illness was
not an aim of the study, without this essential informa-
tion it is difficult to reliably assess the quality of health
worker practice. A further limitation is that the study
did not take into consideration medication supplies at
the respective health facilities in either survey. The sup-
ply of anti-malarial drugs or other medications could
have an implied effect on the prescribing behaviour of
health workers [32]. In addition, health workers in the
OS sample were required to complete a diagnosis and
medication section on a research-specific case report
form which is not reflective of normal practice and
health workers in the CS sample were actively observed
during their respective febrile case consultations by a
member of a research team. This, too, may have influ-
enced health worker practice. The health workers in
both surveys were predominantly nurses and community
health workers. Therefore, the conclusions drawn con-
cerning health worker behaviour are not a complete de-
piction of all health worker cadres in PNG.
The respective datasets also had their inherent weak-
nesses. The OS analyses were based on a large number
of patient cases, yet they had been collectively treated by
a relatively small number of health workers. Conversely,
the CS analyses were based on a smaller number of pa-
tients, yet they had been treated by a larger number of
health workers from a more diverse array of health facil-
ities. Triangulating findings from the two datasets, as
was done here, overcomes their respective limitations in
part. Despite these limitations, the collective sample size
of both patients and health workers, the relatively robust
sampling and study protocols, the geographical spread of
participating health centres and the general agreement
between the two datasets with respect to reported diag-
nosis and prescription practice suggests the reported
findings could reasonably be generalised to health cen-
tres across PNG.
Conclusions
The findings indicate health workers predominantly ad-
here to mRDT negative results, determine alternative
diagnoses in most cases and provide medications other
than antimalarials. However, the findings further suggest
that a large proportion of non-malarial febrile patients
are not being provided a diagnosis, the diagnoses that
are given may not necessarily be accurate, the medica-
tions prescribed rarely fully adhere to those recom-
mended for the specified diagnosis and that antibiotics
are likely to be overprescribed. All of these factors
strongly indicate a need for intensive and continuing
health worker support in the diagnosis and management
of non-malarial fevers and for thorough scientific inves-
tigation and reporting on the aetiology of non-malarial
fevers across the various regions of PNG.
Interventions based on training and/or the provision
of rapid diagnostic tests have demonstrably improved
non-malarial febrile case management [33], and inter-
ventions proven successful in improving malaria case
management, such as text message reminders [34],
would seemingly be easily transferable. General health
systems strengthening in low income country contexts
such as PNG is equally essential to sustained improve-
ment in health worker performance [35]. As multiple
support and supervisory mechanism are typically re-
quired to improve health worker practice [36],
strengthening non-malarial febrile case management in
primary health care contexts in PNG will likely require
a package of health worker and health system
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strengthening interventions, variously focusing on: fur-
ther reducing antimalarial prescription to malaria
mRDT negative patients; encouraging formal diagnosis
and the use of clinical and available laboratory re-
sources to inform diagnosis; rational use of antibiotics;
and adherence to recommended treatment guidelines
when a diagnosis is made.
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